Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis
Simon Witzel, André Maier, Robert Steinbach, et al.
JAMA Neurology (2022) Vol. 79, Iss. 2, pp. 121-121
Open Access | Times Cited: 142

Showing 51-75 of 142 citing articles:

Restoring Axonal Organelle Motility and Regeneration in Cultured FUS-ALS Motoneurons through Magnetic Field Stimulation Suggests an Alternative Therapeutic Approach
Wonphorn Kandhavivorn, Hannes Glaß, T. Herrmannsdörfer, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1502-1502
Open Access | Times Cited: 6
TDP-43-stratified single-cell proteomic profiling of postmortem human spinal motor neurons reveals protein dynamics in amyotrophic lateral sclerosis
Amanda J. Guise, Santosh A. Misal, Richard H. Carson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS)
J. Daniel Bireley, John A. Morren
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 8, pp. 677-683
Closed Access | Times Cited: 6
Therapeutic Effects of Combination of Nebivolol and Donepezil: Targeting Multifactorial Mechanisms in ALS
Soo Yeon Lee, Hye-Yeon Cho, Jung-Pyo Oh, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 6, pp. 1779-1795
Open Access | Times Cited: 6
Selective vulnerability of motor neuron types and functional groups to degeneration in amyotrophic lateral sclerosis: review of the neurobiological mechanisms and functional correlates
Saak V. Ovsepian, Valerie B. O’Leary, Salvador Martı́nez
Brain Structure and Function (2023) Vol. 229, Iss. 1, pp. 1-14
Open Access | Times Cited: 6
Sex dimorphism in the effect and predictors of weight loss after sleeve gastrectomy
Jiaxin Shu, Tao Zhu, Sisi Xiong, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 2
Using an expanded algorithm to estimate prevalence of amyotrophic lateral sclerosis in U.S. and UK
Ali Abbasi, Henrik Fryk, Jan Rudnik, et al.
Neurological Sciences (2024) Vol. 45, Iss. 5, pp. 2321-2324
Closed Access | Times Cited: 2
Evaluating emerging drugs in phase II & III for the treatment of amyotrophic lateral sclerosis
Xiaoyan Li, Richard Bedlack
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 2, pp. 93-102
Open Access | Times Cited: 2
The Role of Human Pluripotent Stem Cells in Amyotrophic Lateral Sclerosis: From Biological Mechanism to Practical Implications
Laura Ceccarelli, Lorenzo Verriello, Giada Pauletto, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 2
Molecular mechanisms and therapeutic strategies for neuromuscular diseases
Alberto A. Zambon, Falzone Yuri Matteo, Bolino Alessandra, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Current neuroprotective therapies and future prospects for motor neuron disease
Laura J. Evans, David O’Brien, Pamela J. Shaw
International review of neurobiology (2024), pp. 327-384
Closed Access | Times Cited: 2
The Role of Patient-Reported Outcomes to Measure Treatment Satisfaction in Drug Development
Carolina Navas, Alexandra Palmer Minton, Ana Maria Rodriguez-Leboeuf
Patient (2024) Vol. 17, Iss. 6, pp. 603-617
Open Access | Times Cited: 2
Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis
Ryuji Kaji, Yuishin Izumi, Ryosuke Oki
Current Opinion in Neurology (2024) Vol. 37, Iss. 5, pp. 593-602
Closed Access | Times Cited: 2
Clinical features and progress in diagnosis and treatment of amyotrophic lateral sclerosis
Dongxiang Yuan, Shishi Jiang, Renshi Xu
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 2
Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis
Mengxia Gao, Lingqun Zhu, Jingling Chang, et al.
Clinical Drug Investigation (2022) Vol. 43, Iss. 1, pp. 1-11
Closed Access | Times Cited: 10
Assessment of Therapeutic Response of Edaravone and Riluzole Combination Therapy in Amyotrophic Lateral Sclerosis Patients
Swapnil Samadhiya, Vijay Sardana, Bharat Bhushan, et al.
Annals of Indian Academy of Neurology (2022) Vol. 25, Iss. 4, pp. 692-697
Open Access | Times Cited: 7
Nanodiagnostics and nanomedicines for neurodegenerative disorders
Kunjbihari Sulakhiya, Anglina Kisku, Rishi Paliwal, et al.
Elsevier eBooks (2023), pp. 131-163
Closed Access | Times Cited: 4
Defects in Glutathione System in an Animal Model of Amyotrophic Lateral Sclerosis
Franziska T. Wunsch, Nils Metzler‐Nolte, Carsten Theiß, et al.
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1014-1014
Open Access | Times Cited: 4
Iranian clinical practice guideline for amyotrophic lateral sclerosis
Reza Boostani, Nahid Olfati, Hosein Shamshiri, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 4
Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study
Elisabetta Zucchi, Umberto M. Musazzi, Guido Fedele, et al.
EClinicalMedicine (2023) Vol. 65, pp. 102256-102256
Open Access | Times Cited: 4
Computational analysis of five neurodegenerative diseases reveals shared and specific genetic loci
Francesca Maselli, Salvatore D’Antona, Mattia Utichi, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 5395-5407
Open Access | Times Cited: 4
Analyzing the ER stress response in ALS patient derived motor neurons identifies druggable neuroprotective targets
Michelle E. Watts, Richard M. Giadone, Alban Ordureau, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 1
Genetic Myelopathies
Kara Stavros
CONTINUUM Lifelong Learning in Neurology (2024) Vol. 30, Iss. 1, pp. 119-132
Closed Access | Times Cited: 1
The Endocannabinoid System as a Potential Therapeutic Target for Amyotrophic Lateral Sclerosis
Kamila Saramak, Natalia Szejko
IntechOpen eBooks (2024)
Open Access | Times Cited: 1
Knockdown of tgfb1a partially improves ALS phenotype in a transient zebrafish model
David González, Xiomara Cuenca, Miguel L. Allende
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1

Scroll to top